Tet enzymes oxidise 5-methyl-deoxycytidine (mdC) to 5-hydroxymethyl-dC (hmdC), 5-formyl-dC (fdC) and 5-carboxy-dC (cadC) in DNA. It was proposed that fdC and cadC deformylate and decarboxylate to dC in the course of an active demethylation process. This would re-install canonical dC bases at previously methylated sites. The question whether such direct C-C bond cleavage reactions at fdC and cadC occur in vivo remains an unsolved problem. Here we report the incorporation of synthetic isotope-and (R)-2'-fluorine-labelled dC and fdC-derivatives into the genome of cultured mammalian cells. Following the fate of these probe molecules using UHPLC-MS/MS provided quantitative data about the formed reaction products. The data show that the labelled fdC probe is efficiently converted into the corresponding labelled dC, most likely after its incorporation into the genome. This allows concluding that fdC is undergoing C-C bond cleavage in stem cells that leads to the direct re-installation of unmodified dC.
Introduction
Modification of genomic cytosine modulates the interaction of DNA-binding factors to the genome, thus affecting gene expression and chromatin structure. The primary and most prevalent modification is methylation to 5-methylcytidine (mdC), which in mammals is catalyzed by the DNA methyltransferases Dnmt1, 3a and 3b, at least partly in co-operation with the catalytically inactive Dnmt3l. Because Dnmt1 is a maintenance methyltransferase that copies the methylation pattern during replication, the information that they convey is inherited through cell division. Genomic mdC can be iteratively oxidised to 5-hydroxymethyldeoxycytidine (hmdC) 1,2 , 5-formyldeoxycytidine (fdC) 3, 4 , and 5-carboxydeoxycytidine (cadC) 4, 5 by the Ten-eleven translocation (Tet) family of -ketoglutarate dependent dioxygenases (Fig. 1a) . These oxidised cytidine derivatives are prominently detected in DNA isolated from neuronal tissues 2, 6, 7 and in the genome of embryonic stem cells (Fig. 1b) , where their levels change during differentiation. 1, 4, 8 For example, hmdC can reach levels of up to 1.3% per dG in DNA isolated from brain. 9 While the presence of mdC and hmdC is believed to influence the transcriptional activity of genes 10, 11 , no clear function could yet be assigned to the higher oxidised modifications fdC and cadC. Recent reports, however, show that fdC is a stable 12 or at least semistable 13 base in the genome. These discoveries and the finding of specific reader proteins that recognise fdC and cadC suggest that they might have regulatory purposes as well. [14] [15] [16] [17] So far, however, fdC and cadC are mainly considered to be intermediates of an active demethylation process that allows cells to replace mdC by a canonical dC nucleotide. [17] [18] [19] One such scenario involves that fdC and cadC are substrates of the Thymine-DNA glycosylase (Tdg), which cleaves the corresponding glycosidic bond.
This converts fdC and cadC into abasic sites, which are further processed through base excision repair (BER) as depicted in figure 1a . This Tdg-initiated process establishes an active demethylation pathway, which ultimately incorporates unmodified dC nucleotides at former fdC and cadC sites. 5, 20 A problem associated with the mechanism is that the removal of every mdC creates a potentially harmful single strand break intermediate. In case another mdC is close to the first in the opposite DNA strand, even double strand breaks may be generated. In addition to these concerns, it was shown that both maternal and paternal genomes of mouse zygotes undergo active demethylation independently of Tdg. 21 To explain this and provide an alternative to the generation of harmful repair intermediates, it was suggested that fdC and cadC may directly deformylate and decarboxylate, respectively, under C-C bond cleavage (Fig. 1a) . 6, 22 Indeed, chemical pathways that allow such a direct deformylation and decarboxylation of fdC and cadC have been described. 23, 24 They involve addition of a helper nucleophile to the C6-position of fdC and cadC in a Michael-addition-type reaction, followed by deformylation or decarboxylation and final elimination of the helper nucleophile. 23 The chemistry is therefore quite similar to the known reaction mechanisms employed by the Dnmt proteins. Although chemically plausible, it is unclear if such direct C-C bond cleavage reactions occur within the genome. 25 This process would provide a new and harmless way to convert mdC back into dC in the genome without the formation of potentially harmful abasic site intermediates.
Here we report a sensitive mass spectrometry-based isotope tracing study to investigate if a C-C bond cleavage reaction occurs on fdC bases (Fig. 1c) . We supplemented the medium of cultured mammalian cells with synthetic isotope and fluorine labelled fdC derivatives to metabolically integrate the nucleosides as reporter molecules into their genome. After isolation of the genomic DNA, the levels of the modified dC derivatives were measured by ultra-high pressure liquid chromatography coupled to tandem mass spectrometry (UHPLC-MS/MS), thereby tracing isotopically or fluorine-labelled dC derivatives. 
Results

Isotopically labelled fdC is directly converted into dC in mouse embryonic stem cells
We started the study with a [ shows that cleavage of the glycosidic bond is the dominant fragmentation pathway. This leads to a clearly detectable fingerprint mass transition of m/z = 263.1 → m/z = 142.1 (Fig. 2b) . As an example, detection of the demodified product dC 2 would be possible based on its mass transition from m/z = 235.1 to m/z = 114.0. For the experiment, we added 1 to the medium of mouse embryonic stem cells (mESCs) under priming conditions. After three days, the genomic DNA was isolated using a standard protocol and digested to the individual nucleosides. The obtained nucleoside mixture was analysed by UHPLC coupled to a triple quadrupole mass spectrometer. We noted that 1 was indeed metabolically incorporated into the genome of mESCs. The mass transition of 1 (m/z = 263.1 → m/z = 142.1) was clearly detectable at a retention time of 5.50 min under our conditions (Fig. 2b) . By using the mass transitions specific for all the expected natural dC-derivatives, we were also able to detect next to 1, mdC, hmdC and fdC (Fig. 1b) . ]-fdC is indeed demodified (Fig. 2c) . In order to unequivocally prove the identity of 2, an even heavier isotopically modified dC-isotopologue [ was added to the nucleoside mixture and it eluted at the same retention time as 2 ( Fig. 2c) (Fig. 2d) . We observed higher levels of product 2 (up to a factor of 10), as shown in figure 2d.
While we can exclude spontaneous deformylation of 1 based on previous stability studies 23 , 2 can in principle form either by C-C bond cleavage in the genome or at the level of the soluble nucleoside/nucleotide pool. Conversion of 1 in the soluble pool to 2 would then be followed by metabolic incorporation of the 2-triphosphate into the genome. It is known that soluble 2 is the substrate for other metabolic processes such as deamination to 3 (catalysed by cytidine deaminase and deoxycytidylate deaminase) followed by methylation by thymidylate synthase to give 4. 26, 27 In order to distinguish the two possible conversion scenarios (genomic DNA vs. soluble pool), we reasoned that if 1 is converted into 2 in the soluble pool, we must find compounds 3 and particularly although such a scenario cannot be fully ruled out due to the complexity of the metabolic pathways ( Supplementary Fig. 3 ). Interestingly, we also noted the presence of the re-methylated product 6 in the genome of mESCs fed with 1, but due to the low signal intensity, we were unable to obtain quantitative data (Fig. 2d ).
(R)-2'-fluorinated cytosines are useful probes for biochemical conversions in vivo
In order to reach higher sensitivity, we experimented with various other isotope labelled fdC derivatives and finally found that 2'-fluorinated dC derivatives 10 -17 are excellent probe molecules ( Fig. 3a and Supplementary Fig. 4 ). The F-atom makes the compounds 18 atom units heavier. The compounds have a slightly shifted retention time (Fig. 3b) and give sharp signals in the UHPLC-MS/MS analysis because of a glycosidic bond that is more labile in the MS-fragmentation step. Furthermore, the 2'-(R)-configured compounds are well tolerated by the cells used for this study. The F-substituent does affect the ability of the molecule to undergo further biochemical conversions, but the effect is small. (R)-2'-F-dC 10 is for example efficiently methylated by DNA methyltransferases 28 and (R)-2'-FmdC 11 is also oxidised to (R)-2'-F-hmdC 12 by the Tet enzymes (Fig. 3a+c ), although here a reduced speed of oxidation is observed. 29 To show that the fluorinated compounds are valid probe molecules, we first added 10 to the mESC culture at 0.5 µM, 1.0 µM or 2.5 µM for three days. Under these conditions, UHPLC-MS/MS analysis of the isolated genomic DNA showed a clear dose-dependent integration of 10 into the genome, up to 1x10 -3 per dN. We next searched for other 2'-fluorinated pyrimidine nucleosides and detected a dosedependent presence of (R)-2'-F-dU 13 and (R)-2'-F-dT 14, formed by deamination of 10 to 13 followed by methylation to 14 (Fig. 3c ). In addition, we detected a dose-dependent formation of (R)-2'-F-mdC and (R)-2'-F-hmdC, confirming that compound 10 is biochemically converted as expected (Fig. 3c) .
In order to quantify the levels of methylation, we synthesized the isotope labelled compounds N2]-F-fdC 20 and used them as internal standards for quantification (Fig. 3a) . Upon feeding mESCs with 1 µM 10 for three days, we detected around 3% (±0.5%) of 11 relative to 10, which is similar to what is observed for the natural bases ( Supplementary Fig. 5 ). 
(R)-2'-F-fdC is converted into (R)-2'-F-dC within the genome of mESCs
To study the direct C-C bond cleavage process, we again cultured mESCs in the presence of (R)-2'-F- /dN), we detected (R)-2'-F-dC at a level of 7.3x10 -6 /dN (Fig. 3d) . Because the nucleosides 13/14 were not detected, we suspected again that the observed reaction 15 → 10 occurs directly within the genome. The detection limit of 13 and 14 is, however, around 5 fmol and so the compounds may just escape observation.
In order to substantiate the conclusion that genomic 15 undergoes intra-genomic C-C bond cleavage to 10, we asked first if 15 could spontaneously deformylate. To investigate this possibility, an aqueous solution of 15 was heated to 60 °C for three days, but compound 10 was not detected. We also incubated 15 in culture medium for three days and were unable to detect any 10. Finally, we added a 28mer oligonucleotide containing a single 15 to culture medium for three days, re-isolated the DNAstrand and searched for 10. Formation of 10 was again not detected. Together these experiments exclude background deformylation.
We next analysed the possibility that 15 is contaminated with traces of 10. To this end, the purity of 15 was checked by MS and indeed 10 was not found. In order to exclude the presence of even traces of 10 below the detection limit, we performed three consecutive HPLC purifications of 15. This compound 15 is well separable from 10 because of a large retention time difference of 7.50 min, using our gradient (Fig. 3e) . Feeding of the material 15 obtained from three consecutive purifications resulted in unchanged values of genomic 10, arguing against the possibility that the detected 10 is an accumulated impurity (Fig. 3f) .
To further substantiate that the C-C bond cleavage does not occur in the soluble nucleoside/nucleotide pool, we added 10 to the mESC culture for three days. UHPLC-MS/MS analysis of the soluble pool allowed us to detect 10, 14 and in traces 13 (Fig. 3g) . However, when we repeated the study with 15
( Fig. 3h) , we detected just 15 in the soluble pool, plus the deaminated compound (R)-2'-F-dC 17, but not 10. We next determined the medium concentration of 10 that would be needed to reach the measured value for genome integrated 10 (7.3x10 -6 /dN, Fig. 3d ) and found that a concentration of 5-10 nM would be required ( Supplementary Fig. 6 ). With a detection limit of 30 amol for 10 (40 L injection), this is a concentration at which 10 is unambiguously detectable.
All these control experiments support the idea that the C-C bond cleavage to F-dC does occur within the genome. Interestingly, upon feeding of 15 we also detected the methylated derivative 11, demonstrating that the demodified product 10 is methylated to 11 in the genome. (Fig. 3a) , we see that re-methylation of 10 provides levels of 2.8% (±0.3%) F-mdC (Fig. 3d) , which is only slightly lower compared to what was observed when we fed 10 directly (Supplementary Fig. 5 ).
To study the time dependence of the C-C bond cleavage process, we fed compound 15 and measured the genome-integrated levels of 15, 10 and 11. Already at 0.5 h, we detected a stable incorporation of 15 (Fig. 4a) . The C-C bond cleaved product 10 appears after about 1 h and here the levels increase steadily (Fig. 4b ). After about 4 h, we see the first re-methylated product 11 (Fig. 4c) . If 10 were a contamination in the preparation of 15, we would expect faster incorporation kinetics. When we fed both 15 and 10 simultaneously, a steady increase in the level of 10 was already observed after 5 min ( Supplementary Fig. 7 ), confirming that our probe nucleosides are quickly incorporated into the genome. These data show that the C-C bond cleavage is a rapid process. 
Demodification of (R)-2'-F-fdC does not require Dnmt or Tet enzymes and occurs also in somatic cell types
In order to investigate if the re-methylation of 10 is driven by the known DNA methyltransferases and whether these are involved in demodification, we added 15 (350 µM, 3 d) to mESCs deficient of all active DNA methyltransferases Dnmt1, 3a and 3b (Dnmt triple knockout or TKO) and analysed the DNA.
In this experiment, the demodified product 10 is again detected, but the methylated product 11 is not seen ( Fig. 4d and Supplementary Fig. 8 ), showing that DNA methyltransferases are responsible for methylation of 10 and are not required for demodification of 15. We finally investigated if the Tetenzymes are involved in demodification of 15. Repeating the feeding experiment with mESCs lacking all three members of the Tet family (Tet triple knockout or TKO) showed however full demodification activity ( Fig. 4e and Supplementary Fig. 9 ). The fact that the conversion 15 → 10 does not change in the absence of Tet proteins is particularly noteworthy. Because Tet enzymes were shown to accept 11 as a substrate converting it into 12, 15 and also (R)-2'-F-cadC 16, 29 we can exclude that the observed C-C bond cleavage is in fact a Tet-dependent decarboxylation of 16. Indeed, this result implies either that 15 is directly deformylated to 10 or that factors other than Tet enzymes can oxidise 15 to 16, which is then decarboxylated to 10. Ascorbic acid has been shown to increase Tet enzymatic activity in vitro and the levels of oxidised mdC derivatives in vivo. [30] [31] [32] Ascorbic acid treatment of mESC cultures fed with 15 indeed resulted in increased levels of naturally occurring fdC and cadC, but had no effect on conversion of 15 into unmodified product 10 ( Supplementary Fig. 10 ). This further supports that demodification of 15 to 10 does not depend on the enzymatic activity of the Tet enzymes.
Finally, we tested whether conversion of 15 into 10 occurs in non-pluripotent cells by feeding 15 to cell lines representing a variety of cell types ( Fig. 4f and Supplementary Fig. 11 ). Albeit to various degrees, we detected the 15 → 10 conversion in all these cell lines, arguing that it is rather widespread in mammalian cell types. In summary, our data prove that fdC is converted into dC in vivo through C-C bond cleavage and strongly suggest that this conversion is an intra-genomic process.
Discussion
In recent years, several mechanisms for active erasure of cytosine methylation from the genome have been proposed. Among these, the best-established mechanism entails Tet-mediated iterative oxidation of mdC to fdC or cadC, followed by the replacement of these higher oxidised derivatives with unmodified dC through BER. Considering the frequent occurrence of mdC in high-density clusters and its prevalent symmetrical configuration at CpG sites in vertebrate genomes, a BER-based erasure mechanism poses a substantial risk of creating clustered single and double strand breaks with potentially deleterious consequences. It is possible that excision of fdC and cadC by Tdg, processing of the abasic site and insertion of unmodified dC are orchestrated by a single multi-molecular complex, thus allowing tight control of strand breaks. Alternatively, it is also conceivable that, in order to minimize the potentially deleterious consequences of BER, complementary mechanisms are in place to remove fdC and cadC without involving DNA repair. In this context, it should be kept in mind that
Tet3-dependent active demethylation of maternal and paternal genomes in the mouse zygote may not require Tdg. 21 With an isotope-tracing experiment, using labelled dC-derived nucleosides in combination with highly sensitive UHPLC-MS/MS detection, we show here that in mammalian cells fdC is converted to dC while keeping the glycosidic bond intact. Evidence is provided that the C-C bond cleavage reaction happens when fdC is located inside the genome. This establishes an intra-genomic demodification process, independent of DNA repair. We also show that this process does not require any of the Tet-family enzymes. Therefore, unless other factors are able to oxidise fdC to cadC, this demodification process is likely a direct deformylation of fdC. Although we have firmly established the occurrence of a C-C bond cleavage of fdC/cadC to dC, the mechanism of this process remains to be defined, including the identification of the factors that mediate the demodification reactions.
We would like to emphasize that in our approach the probe nucleosides are randomly incorporated into the genome through DNA replication. Consequently, we cannot determine the sequence and genomic context where the demodification of fdC/cadC to dC takes place. Obviously, this would require a sequencing approach that allows the identification of the converted dC bases. In addition, as we could detect conversion of 2'-fluorinated fdC to 2'-fluorinated dC in mESCs and different somatic cell types. This indicates that the ability to carry out the demodification reaction may be widespread in mammalian cells and tissues, rather than being restricted to events of active genomic demethylation known to occur in specific developmental and tissue contexts. Assuming that the deformylation of fdC to dC establishes an active demethylation pathway, we need to emphasize that deformylation reactions and deformylases are widespread in nature. A prominent example is the enzyme Lanosterindemethylase (CYP51A1), which oxidises the C-14α-methyl group of lanosterin to a formyl group to achieve deformylation under concomitant introduction of a double bond (dehydrating deformylation).
This enzyme, a P450-type monooxygenase, contains a heme-cofactor that seems to utilise a nucleophilic Fe-peroxylanion species for attacking the substrate. 33, 34 Another well studied enzyme that catalyses deformylation is the Aldehyde-Deformylating-Deoxygenase, which again uses a nucleophilic metal bond peroxylanion radical as the attacking species. This enzyme shortens fatty acid chains by oxidising the terminal methyl group to a formyl group, followed by deformylation. 35, 36 In contrast to fdC, these deformylation reactions take place on formyl groups attached to saturated C-atoms, while in fdC, the formyl group is linked to an aromatic heterocycle. Such structures are known for decarboxylations and they are catalysed by the enzymes orotate 37 and isoorotate 38 decarboxylase.
Indeed, it was suggested that the isoorotate decarboxylase could be a blueprint for a putatively existing cadC decarboxylase. 39 Our data now support the idea that fdC and possibly also cadC are converted to dC by a direct C-C bond cleavage. The questions as to when and where these reactions occur in vivo now requires the identification of putative catalytic factors.
Online Methods
Chemical Synthesis
Synthetic schemes, detailed procedures and characterization of synthesized products can be found in 
Cell culture
Basal medium for mESC culture was DMEM high glucose containing 10% FBS, 2 mM L-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, 1x MEM Non-essential Amino Acid Solution and 0.1 mM β-mercaptoethanol (all from Sigma). All mESC lines were maintained in naïve state on gelatin coated plates by supplementing basal medium with 1000 U/mL LIF (ORF Genetics), GSK3 inhibitor CHIR99021 at 3 µM and Mek inhibitor PD0325901 1 µM ("2i"). Metabolic labelling experiments with fluorine-or isotope-labelled nucleosides were performed by plating mESCs in priming conditions consisting of basal mESC medium supplemented with 3 µM CHIR99021 and Wnt pathway inhibitor IWR1-endo at 2.5 µM as previously reported 40 . Under these conditions primed cells remained pluripotent for at least seven days as determined by epifluorescence with an Oct4-YFP knock-in cell line 41 . Priming and labelling was performed for three days. Over this period naturally occurring genomic mdC and hmdC (Fig. 1b) reached levels similar to those recently reported for epiblast-like cells, which are regarded as the closest in vitro counterpart to non-committed post-implantation epiblast 42, 43 . All inhibitors were purchased from Selleckchem. Dnmt TKO J1 mESCs were described in 44 . Two independent sets of Tet TKO and respective wt mESC lines were used: wt #17 and Tet TKO #3 were reported in 45 and wt #4 and Tet TKO #29 were described in 46 . J1 mESCs are from the 129/Sv/Jae strain, while all Tet TKO and corresponding wt mESC lines are from mixed genetic backgrounds.
The time course experiment was performed by culturing J1 mESCs under priming conditions for 48 h.
The medium was exchanged to priming medium containing 350 µM F-fdC and cells were harvested after 0.5, 1.0, 2.0, 4.0, 8.0, 16 and 24 h, as described.
RBL-2H3, HeLa, NIH3T3 and Neuro-2a cells were cultured in DMEM high glucose containing 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin. CHO-K1 cells were maintained in DMEM/F-12 supplemented as reported above for the other somatic cell lines. ENC1 neural stem cells were cultured as previously described 47 . Cells were exposed to labelled nucleosides for four (RBL-2H3 and NIH3T3), five (CHO-K1), six (Neuro-2a) and seven days (HeLa and ENC1).
Labelled nucleosides were added to the culture medium at the following concentrations: F-fdC (15) 
Isolation of genomic DNA
Cultures were washed with PBS and lysed by adding RLT buffer (Qiagen) containing 400 µM each of 2,6-di-tert-butyl-4-methylphenol (BHT) and desferoxamine mesylate (DM) directly to the plates. 
LC/MS-MS analysis of DNA samples.
Quantitative UHPLC-MS/MS analysis of digested DNA samples was performed using an Agilent 1290 UHPLC system equipped with a UV detector and an Agilent 6490 triple quadrupole mass spectrometer. amount (n) and ratio of the amounts (A/A*) fulfilling the requirements of the corresponding linear equation.
Nucleoside stability test
Compounds 1 and 15 were incubated at 100 µM in mESC culture medium at 37 °C and 5% CO2 for 3 d.
For the recovery of the nucleosides Supel-Select SPE HLB cartridges from Sigma Aldrich were used.
Prior to use, these cartridges were equilibrated with MeOH, H2O and diluted HCl (pH = 4). The pH of the samples was adjusted to 4 and the acidic solution was loaded on the cartridges. After washing with 10 mL of H2O, the cartridges were dried in vacuo. The nucleosides were eluted with MeOH/MeCN (1:1), evaporated to dryness via speedvac and resuspended in H2O.
Oligonucleotide stability test
An oligonucleotide (6.9 pmol) containing one F-fdC (28mer) was incubated in mESC culture medium at Cells were washed twice with PBS (Sigma Aldrich), harvested by trypsinization and pelleted by centrifugation for 3 min at 300 g. 500 µL ice cold 50% (v/v) acetonitrile was added dropwise to the pellet and vortexed. 51 The mixture was incubated on ice for 10 min. The insoluble fraction was then separated from the soluble pool by centrifugation for 10 minutes at 21000 x g at 0 °C. The supernatant was removed and used for nucleoside isolation. The soluble fraction containing the nucleosides was dried by lyophilization and metabolites were purified using Supel-Select SPE HLB cartridges (as described in the Nucleoside stability test) prior to UHPLC-MS/MS analysis.
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